Clinical Evaluation of the Efficacy and Safety of Co-Administration of Wuzhi Capsule and Tacrolimus in Adult Chinese Patients with Myasthenia Gravis
Yuyao Peng, Fei Jiang, Ran Zhou, Wanlin Jin, Yi Li, Weiwei Duan, Liqun Xu, Huan Yang Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, People’s Republic of ChinaCorrespondence: Liqun Xu; Huan YangDepartment of Neurology, Xiangya Hospital, Central South University...
Guardado en:
Autores principales: | Peng Y, Jiang F, Zhou R, Jin W, Li Y, Duan W, Xu L, Yang H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d3da9fffe3e45d39b7fb251a3ff9775 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fetal Surveillance in Pregnancies with Myasthenia Gravis
por: Brîndușa Ana Cimpoca-Raptis, et al.
Publicado: (2021) -
Efficacy and Safety of Immunotherapies in Refractory Myasthenia Gravis: A Systematic Review and Meta-Analysis
por: Xuelin Feng, et al.
Publicado: (2021) -
Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study
por: Sijia Zhao, et al.
Publicado: (2021) -
Research of antibodies to the acetylcholine receptors in patients with myasthenia gravis
por: T. V. Romanova
Publicado: (2013) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
por: Maryam Abbas, et al.
Publicado: (2021)